06.14.23 -- A New Vial Design Capable Of Curbing Delamination And Glass Particulate Generation

Regardless of a company’s size, recognizing the importance of packaging development and prioritizing its role in drug development early on can help you proactively identify events that could delay your timelines and prepare you to develop strategies to overcome the risks.

Glass delamination has contributed to regulatory recalls, placing patients at risk and increasing costs for pharmaceutical manufacturers. Valor Glass represents a significant, and much needed, step forward for glass innovation. Review the study's findings and learn how an aluminosilicate formulation can lower your glass vials' extractables profile.

While quality and safety standards have risen in tandem with the recent wave of biopharmaceutical innovations, pharmaceutical glass containers have remained largely unchanged. A comprehensive solution for multiple glass quality issues that affect drug products is essential to avoid costly delays and drug product recalls, all while increasing patient safety.

Manufacturing planning is a critical step in the path to commercialization and helps companies accelerate their path-to-market. Obtaining information and proactively mapping out your fill/finish strategy early in development can de-risk an investment in equipment or processes, ensuring that you meet your long-term needs.